Millipore Sigma Vibrant Logo

553506 RAP, Human, Recombinant, E. coli

RAP, Human, Recombinant, E. coli: のSDS（安全データシート）、CoA（試験成績書）およびCoQ（品質証明書）、カタログなど製品関連の技術資料を入手いただけます。

同義語: Receptor Associated Protein

View This Product on Sigma-Aldrich
553506
価格＆在庫状況を照会

概要

Replacement Information

価格＆在庫状況

カタログ番号 在庫状況包装 Qty/Pk 価格 数量
553506-50UGCN
在庫状況検索中…
—
現在国内在庫なし 現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service

      		 樹脂ｱﾝﾌﾟﾙ 50 μg
      価格を検索中…
      価格が見つかりません
      Minimum Quantity needs to be mulitiple of
      Maximum Quantity is
      弊社照会 詳細を表示　
      値引
      ()
       
      —
      弊社照会
      		 —
      Description
      OverviewRecombinant, human RAP fused to GST, expressed in E. coli, and subsequently cleaved with thrombin to remove GST. Antagonizes the ligand binding of certain members of the low-density lipoprotein receptor family such as low density lipoprotein receptor-related protein (LRP) and very low-density lipoprotein (VLDL) receptor. Promotes the proper folding and subsequent exocytic trafficking of the wild-type low density lipoprotein receptor (LDLR) and several of its class 2 mutants. Expressed as a GST-fusion protein that is subsequently cleaved with thrombin. Typical concentrations to block LRP or VLDL receptor are 200-300 nM. For antagonism of LDLR, 1 µM is recommended.
      Catalogue Number553506
      Brand Family Calbiochem®
      SynonymsReceptor Associated Protein
      References
      ReferencesLi, Y., et al. 2002. Biochemistry 41, 4921.
      Salicioni, A.M., et al. 2002. J. Biol. Chem. 277, 16160.
      Anderson, O.M., et al. 2001. Biochemistry 40, 15408.
      Bu, G. 2001. Int. Rev. Cytol. 209, 79.
      Williams, S.E., et al. 1992. J. Biol. Chem. 267, 9035
      Product Information
      FormLiquid
      Formulation150 mM NaCl, 100 mM Tris-HCl, pH 7.4.
      Quality LevelMQ100
      Applications
      Biological Information
      Purity≥90% by SDS-PAGE
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      カタログ番号 GTIN
      553506-50UGCN 04055977193664

      Documentation

      RAP, Human, Recombinant, E. coli (M)SDS

      タイトル

      英語版製品安全データシート（(M)SDS） 

      RAP, Human, Recombinant, E. coli 試験成績書（CoA）

      タイトルロット番号
      553506

      参考資料

      参考資料の概要
      Li, Y., et al. 2002. Biochemistry 41, 4921.
      Salicioni, A.M., et al. 2002. J. Biol. Chem. 277, 16160.
      Anderson, O.M., et al. 2001. Biochemistry 40, 15408.
      Bu, G. 2001. Int. Rev. Cytol. 209, 79.
      Williams, S.E., et al. 1992. J. Biol. Chem. 267, 9035
      データシート

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision20-April-2009 JSW
      SynonymsReceptor Associated Protein
      DescriptionRecombinant, human RAP fused to GST, expressed in E. coli, and subsequently cleaved with thrombin to remove GST. Receptor Associated Protein (RAP) antagonizes the ligand binding of certain members of the low-density lipoprotein receptor family such as low-density lipoprotein receptor-related protein (LRP) and very low density lipoprotein (VLDL) receptor. Promotes the proper folding and subsequent exocytic trafficking of the wild-type low-density lipoprotein receptor (LDLR) and several of its class 2 mutants. Typical concentrations used to block LRP or VLDL receptor are 200-300 nM; for antagonism of LDLR, 1 µM is recommended.
      FormLiquid
      Formulation150 mM NaCl, 100 mM Tris-HCl, pH 7.4.
      Concentration Label Please refer to vial label for lot-specific concentration
      Purity≥90% by SDS-PAGE
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesLi, Y., et al. 2002. Biochemistry 41, 4921.
      Salicioni, A.M., et al. 2002. J. Biol. Chem. 277, 16160.
      Anderson, O.M., et al. 2001. Biochemistry 40, 15408.
      Bu, G. 2001. Int. Rev. Cytol. 209, 79.
      Williams, S.E., et al. 1992. J. Biol. Chem. 267, 9035